You Searched For: XMD17-109
378 results were found
~~Glow In the Dark Demonstration~~
/m-ca.vwr.com/en_CA/images/Glow_In_the_Dark_Demonstration.pdf
Ward’s Science Tel: (866) 260-0501 109
~~Glow In the Dark Demonstration~~
/m-us.vwr.com/en_US/images/Glow_In_the_Dark_Demonstration.pdf
Ward’s Science Tel: (866) 260-0501 109
Glow In the Dark Demonstration
/www.boreal.com/images/Glow In the Dark Demonstration.pdf
Ward’s Science Tel: (866) 260-0501 109
A18L14A UHP SEC analysis of biosimilars
/m-uk.vwr.com/en_GB/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/uk.vwr.com/en_GB/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-si.vwr.com/sl_SI/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~product information~~
/uk.vwr.com/en_GB/images/AP_A8360_Myco_1and2_Set.pdf
product information 1 Myco-1&2 Set Myco-1&2 Set (A8360) contains Myco-1 (A5222) Myco-2 (A5233) Product No. A8360 Description Treatment of Mycoplasma-infected Cells with Antibiotics The contamination of cells with mycoplasma is a very common proble...
~~A18L14A UHP SEC analysis of biosimilars~~
/it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-se.vwr.com/sv_SE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
product information
/m-uk.vwr.com/en_GB/images/AP_A8360_Myco_1and2_Set.pdf
product information 1 Myco-1&2 Set Myco-1&2 Set (A8360) contains Myco-1 (A5222) Myco-2 (A5233) Product No. A8360 Description Treatment of Mycoplasma-infected Cells with Antibiotics The contamination of cells with mycoplasma is a very common proble...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/fr_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-fr.vwr.com/fr_FR/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-dk.vwr.com/da_DK/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-in.vwr.com/en_IN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/de_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
1 - 16 of 378